Log in or Sign up for Free to view tailored content for your specialty!
Rheumatoid Arthritis News
Long-term TNF inhibitor use in rheumatoid arthritis not linked to increased cancer risk
There is no increased risk for cancer overall associated with the long-term use of TNF inhibitors for rheumatoid arthritis, according to data published in Rheumatology.
NIH opens study of COVID-19 vaccine booster in patients with autoimmune disease
The NIH has launched a clinical trial to examine antibody responses to a COVID-19 vaccine booster dose in patients with autoimmune disease who failed to respond to the initial vaccine regimen.
Log in or Sign up for Free to view tailored content for your specialty!
Inflammatory arthritis diagnosis prior to age 30 years 'impairs' male fertility
Male patients diagnosed with inflammatory arthritis at or before peak reproductive age have a lower fertility rate, a higher childlessness rate, and more fertility issues, according to data published in the Annals of the Rheumatic Diseases.
Physician's exercise recommendations 'critical' to relieving arthritis symptoms
Among patients with arthritis, receiving exercise recommendations from a physician is “critical” to meeting physical activity guidelines and relieving symptom burden, regardless of race and ethnicity, researchers noted in BMC Public Health.
Immunosuppressants remain ‘cornerstone’ therapy for CTD-ILD as drug options emerge
Although immunosuppressives remain the cornerstone for managing underlying interstitial lung disease in connective tissue diseases, new drug approvals could help shift the treatment paradigm, according to data presented here.
Cancer screening recommendations in autoimmune disease rely on experience in lieu of data
Cancer screening recommendations for patients with autoimmune diseases largely rely on clinical experience and extrapolation in the absence of abundant data, according to a speaker at the 2021 Congress of Clinical Rheumatology-East meeting.
Methotrexate mainstay: ACR guidelines reaffirm old DMARD as ‘anchor drug’ in RA therapy
Maximizing the disease-modifying benefits of methotrexate is one of the core principles behind the 2021 American College of Rheumatology rheumatoid arthritis guidelines.
Hidradenitis suppurativa treatment should be 'layered,' address psychosocial impacts
Providers should avoid monotherapy when treating hidradenitis suppurativa, and instead use a “layered and rotated” approach that also addresses the isolating psychosocial aspects of the disease, noted a speaker here.
Lung disease in RA filled with 'bad players'
A wide array of potential etiologies can cause lung disease in rheumatoid arthritis patients, according to a presenter at the 2021 Congress of Clinical Rheumatology-East.
Expanding drug armamentarium offers 'light at the end of the tunnel' for patients with RA
The advent of biologics and other immunomodulatory options provides hope for patients with rheumatoid arthritis, according to a speaker at the 2021 Rheumatology Nurses Society annual conference.
-
Headline News
Rise in alcohol use during pandemic endures as 'an alarming public health issue'
November 14, 20242 min read -
Headline News
AI identified patient messages sent by proxies, but also broke confidentiality
November 14, 20242 min read -
Headline News
Diabetes inequities persist worldwide, especially for low-, middle-income countries
November 14, 20243 min read
-
Headline News
Rise in alcohol use during pandemic endures as 'an alarming public health issue'
November 14, 20242 min read -
Headline News
AI identified patient messages sent by proxies, but also broke confidentiality
November 14, 20242 min read -
Headline News
Diabetes inequities persist worldwide, especially for low-, middle-income countries
November 14, 20243 min read